Details

Archived 19: Summary of National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following a 1- or 2-dose primary series - Canada.ca

Metadata and links for an archived snapshot.

Source
Public Health Agency of Canada
Date
Feb 3, 2026 · edition #7
Timestamp
2026-02-03T01:11:07.642Z
Language
en
Original URL
https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/summary-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html
Replay URL
https://replay.healtharchive.ca/job-7/20260203011107/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/summary-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html#ha_snapshot=748485
ID
748485
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview